Influence of Adherence to Growth Hormone Therapy (GHT) With Norditropin® on Near Final Height in Patients With Growth Hormone Deficiency (GHD) and Born Small for Gestational Age (SGA)
Clinical trial NCT03972345 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT03972345
- Sponsor
- Novo Nordisk A/S
- Status
- ENROLLING_BY_INVITATION
- Study type
- OBSERVATIONAL
- Start date
- 2019-06-21
- Primary completion
- 2029-06-30
- Enrollment
- 750
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.